| Literature DB >> 27182309 |
Vanessa D Sherk1, Clint D Howard1, Michael G Bemben1, Debra A Bemben1.
Abstract
In premenopausal women, low bone density may reflect attainment of a lower peak bone mass which can increase risk of osteoporosis after menopause. The purpose of this study was to examine the relationship between total body, lumbar spine, and proximal femur bone mineral density (BMD) and body composition and oral contraceptive (OC) use in 18-30 year old women. Sixty-five healthy women, split into groups of oral contraceptive users (OC, n = 36) and non oral contraceptive users (Non-OC, n = 29), completed Baecke physical activity, calcium intake, and menstrual history questionnaires. Total body, AP lumbar spine, and dual proximal femur scans were performed using Dual Energy X-Ray Absorptiometry (DXA). Body composition measures were obtained from the total body scan analysis. No significant differences were found for BMD in OC users and non-users. Bone free lean body mass (BFLBM) and weight were positively correlated to all BMD sites, and fat mass was related to total body and L1-L4 spine BMD (p < 0.05). Stepwise regression analyses determined that weight was a significant predictor for all BMD sites (p < 0.05). When separating the two components of body weight, BFLBM was a significant predictor for all BMD sites, and fat mass only predicted total body BMD. In conclusion, this study indicates that weight and BFLBM are significant contributors to BMD in young healthy premenopausal women, and OC use did not influence the relationship between BMD and BFLBM.Entities:
Keywords: DXA; Hormonal contraceptives; bone density; bone free lean body mass
Year: 2009 PMID: 27182309 PMCID: PMC4739492
Source DB: PubMed Journal: Int J Exerc Sci ISSN: 1939-795X
Subject Characteristics (Mean ± SE)
| Variables | All Subjects (n = 65) | OC | Non-OC (n = 29) |
|---|---|---|---|
| Age (yrs) | 22.7 ± 0.4 | 22.7 ± 0.4 | 22.8 ± 0.6 |
| Height (cm) | 164.6 ± 0.7 | 163.6 ± 0.9 | 165.9 ± 1.0 |
| Weight (kg) | 56.5 ± 0.8 | 57.5 ± 1.1 | 55.3 ± 1.1 |
| BMI (kg/m2) | 20.9 ± 0.3 | 21.5 ± 0.4 | 20.1 ± 0.4 |
| Body fat % | 27.0 ± 0.7 | 28.2 ± 0.9 | 25.6 ± 1.0 |
| Fat mass (kg) | 15.2 ± 0.5 | 16.1 ± 0.7 | 14.0 ± 0.7 |
| BFLBMd (kg) | 37.8 ± 0.5 | 37.9 ± 0.7 | 37.7 ± 0.7 |
| Calcium Intake (mg/day) | 1001 ± 59 | 1081 ± 89 | 902 ± 72 |
| Total PA | 8.6 ± 0.2 | 8.7 ± 0.3 | 8.5 ± 0.3 |
p ≤ 0.05 Significantly different from Non-OC.
OC, Oral Contraceptive Users
BFLBM, Bone Free Lean Body Mass.
PA, Physical Activity
Bone mineral density (BMD) and bone mineral content (BMC) values based on oral contraceptive use (Mean ± SE)
| Site | All Subjects (n = 65) | OC | Non-OC (n = 29) |
|---|---|---|---|
| BMD (g/cm2) | 1.162 ± 0.017 | 1.183 ± 0.025 | 1.136 ± 0.023 |
| BMC (g) | 59.20 ± 1.12 | 59.86 ± 1.48 | 58.37 ± 1.72 |
| BMD (g/cm2) | 1.077 ± 0.019 | 1.098 ± 0.026 | 1.051 ± 0.027 |
| BMC (g) | 4.78 ± 0.10 | 4.88 ± 0.16 | 4.65 ± 0.12 |
| BMD (g/cm2) | 0.830 ± 0.018 | 0.854 ± 0.023 | 0.800 ± 0.027 |
| BMC (g) | 8.88 ± 0.26 | 9.07 ± 0.34 | 8.64 ± 0.39 |
| BMD (g/cm2) | 1.048 ± 0.021 | 1.072 ± 0.029 | 1.018 ± 0.030 |
| BMC (g) | 30.16 ± 0.64 | 30.75 ± 0.92 | 29.44 ± 0.88 |
| BMD (g/cm2) | 1.156 ± 0.010 | 1.166 ± 0.014 | 1.144 ± 0.015 |
| BMC (kg) | 2.49 ± 0.04 | 2.51 ± 0.06 | 2.47 ± 0.06 |
No significant differences (p > 0.05) between groups.
OC: Oral Contraceptive Users
Relationships of bone mineral density with physical activity, calcium intake, and bone free lean body mass for all women.
| Fat Mass | BFLBM | Weight | PA | OC | Ca2+ Intake | |
|---|---|---|---|---|---|---|
| Total Body BMD | 0.31 | 0.53 | 0.55 | 0.31 | 0.02 | 0.16 |
| Spine LI–L4 BMD | 0.26 | 0.41 | 0.45 | 0.23 | 0.14 | 0.12 |
| Femoral Neck | 0.17 | 0.55 | 0.47 | 0.31 | 0.07 | 0.01 |
| BMD | ||||||
| Trochanter BMD | 0.17 | 0.51 | 0.44 | 0.23 | 0.10 | 0.01 |
| Total Hip BMD | 0.21 | 0.55 | 0.49 | 0.30 | 0.02 | −0.02 |
| PA Score | −0.02 | 0.43 | 0.28 | . | 0.03 | 0.07 |
| OC Duration | 0.25 | 0.04 | 0.19 | 0.03 | . | 0.18 |
p < 0.05.
p < 0.0l.
BFLBM, Bone Free Lean Body Mass.
PA, Total Physical Activity Score
OC, Oral Contraceptive
BMD, Bone Mineral Density
Predictors of bone mineral density (BMD) with weight, calcium intake, oral contraceptive use and physical activity as independent variables.
| Dependent Variable: BMD (g/cm2) | Significant Predictors | β | SEE | R2 |
|---|---|---|---|---|
| Total Body | Weight | 0.55 | 0.069 | 0.292 |
| Spine L1–L4 | Weight | 0.452 | 0.124 | 0.192 |
| Femoral Neck | Weight | 0.466 | 0.136 | 0.205 |
| Trochanter | Weight | 0.444 | 0.129 | 0.184 |
| Total Hip | Weight | 0.488 | 0.148 | 0.226 |
p < 0.01
Predictors of bone mineral density (BMD) with bone free lean body mass (BFLBM), fat mass, calcium intake, oral contraceptive use and physical activity as independent variables.
| Dependent Variable: BMD (g/cm2) | Significant Predictors | β | SEE | R2 |
|---|---|---|---|---|
| Total Body | BFLBM | 0.490 | 0.068 | 0.309 |
| Fat Mass | 0.228 | |||
| Spine L1–L4 | BFLBM | 0.410 | 0.127 | 0.155 |
| Femoral Neck | BFLBM | 0.552 | 0.128 | 0.293 |
| Trochanter | BFLBM | 0.506 | 0.124 | 0.244 |
| Total Hip | BFLBM | 0.550 | 0.141 | 0.292 |
p < 0.05.
p < 0.0l.